Albert Garcia-Romeu, Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Drug Abuse Intramural Neuroimaging Research Branch, where he studies the effects of psychedelic drugs in humans, with a focus on psilocybin as an aid in the treatment of addiction.
June 5, 2018
Rhana Hashemi is the site coordinator for drug and alcohol programs and services for Oakland Unified School District. But, to her students, she is just “the drug lady.”
June 14, 2018
Before I met Adam I didn’t really know anyone with OCD. It was just an abstract concept to me. Like most people, I had the image of the stereotypical germaphobe who obsessively scrubs their hands in a futile attempt at washing the thousands of bacteria away.
June 18, 2018
Like the vast majority of psychonauts, I didn’t use a chemical reagent to verify I was taking LSD, even though I had been active in harm reduction work for three years prior and was aware of testing kits.
July 3, 2018
Today, we have a world where we can say: “I’m proud to be a woman” and “I’m proud to be gay.” But we can’t say: “I’m a drug-user.”
July 19, 2018
A conversation between two (white) activists to further the dialogue around inclusivity in the field of psychedelic research and culture.
July 23, 2018
A team of researchers bathed octopuses in MDMA. Here's what they learned.
July 26, 2018
Clashes between SSDP and New College administrators represent growing confusion about handling harm reduction on campuses
August 21, 2018
We spoke with an experienced psychiatrist about how exactly prescribing ketamine for depression works.
August 22, 2018
Four years since that trip, I’m no longer prescribed antidepressants.
September 5, 2018
Narratives which gloss-over the history and socioeconomic dynamics of ayahuasca’s globalization may, despite good intentions, actually do more harm than good.